Health News Review Archives

Stem cell news bites: Mesoblast, BioTime, MS, FDA Warning, & More

June 14, 2016 Paul Knoepfler 4

Stem cell studies continue to make big news with a mixed bag of trends, and some good stem cell news and others not so much. Mesoblast ($MESO) had its stock suspended for quite so time recently in anticipation of a […]

Science press releases behaving badly: time to start tracking their retractions?

January 14, 2016 Paul Knoepfler 3

Over at RetractionWatch, their team does a great job following retractions of science papers. Sadly, the number of published manuscript retractions gives them more than enough material to post several times a day. There’s another phenomenon going on that I […]

The Niche

Knoepfler lab stem cell blog

Health News Review

Stem cell news bites: Mesoblast, BioTime, MS, FDA Warning, & More

Science press releases behaving badly: time to start tracking their retractions?